Menstrual disorders during adolescence

Pediatric Endocrinology Reviews

Volumn 3, Issue SUPPL. 1, 2006, Pages 150-159

  Deligeoroglou, E ^a   Tsimaris, P ^a   Deliveliotou, A ^a   Christopoulos, P ^a   Creatsas, G ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Adolescence; Dysfunctional Uterine Bleeding; Dysmenorrhea; Menstrual Disorders

Indexed keywords

ALPHA TOCOPHEROL; ANTIEMETIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CONJUGATED ESTROGEN; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTROGEN; GESTAGEN; GLYCERYL TRINITRATE; IRON; LEVONORGESTREL; LOW DOSE ORAL CONTRACEPTIVE; MAGNESIUM; MEDROXYPROGESTERONE ACETATE; NAPROXEN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; ORAL CONTRACEPTIVE AGENT; PLACEBO; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRIDOXINE; SPASMOLYTIC AGENT; THIAMINE; VERAPAMIL;

ADOLESCENT; ANEMIA; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CURETTAGE; DYSMENORRHEA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYSTEROSCOPY; MENARCHE; MENSTRUAL CYCLE; MENSTRUATION DISORDER; META ANALYSIS; METRORRHAGIA; NAUSEA; OLIGOMENORRHEA; PHYSICAL EXAMINATION; PHYSICIAN; PREMENSTRUAL SYNDROME; PRIMARY AMENORRHEA; SECONDARY AMENORRHEA; SYSTEMATIC REVIEW; UTERUS BLEEDING; VOMITING;

ADOLESCENT; FEMALE; HUMANS; MENSTRUAL CYCLE; MENSTRUATION DISTURBANCES;

EID: 33645395081     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (71)

1. Hickey M, Balen A. Menstrual disorders in adolescence: investigation and management. Hum Reprod Update 2003;9:493-504
2. Apter D, Viinikka L, Vihko R. Hormonal patterns of adolescent menstrual cycles. J Clin Endocrinol Metab 1978;47:944-954
3. Lemarchand-Beraud et al. Maturation of the hypothalamo-pituitary-ovarian axis in adolescent girls. J Clin Endocrinol Metab 1982;54:241-246
4. Fraser IS, Hickey M, Song JY. A comparison of mechanisms underlying disturbances of bleeding caused by spontaneous dysfunctional uterine bleeding or hormonal contraception. Hum.Reprod. 1996;11:165-178
5. Smith SK. Angiogenesis, vascular endothelial growth factor and the endometrium. Hum Reprod Update 1998;4:509-519
6. Fraser IS, Sungurtekin U. Defining menstrual disturbances. In: Maclean A and O'Brien, P.M.S. (eds) Study Group on Menstrual Disorders. Royal College of Obstetricians and Gynecologist 2000;141-152
7. Deligeoroglou E. Dysfunctional uterine bleeding. Annals of the New York Academy of Science 1997;186:158-164
8. Slap GP Menstrual Disorders in adolescence. Best Pract Res Clin ObGyn 2003;17:75-92
9. Claessens EA and Cowell CA. Acute adolescent menorrhagia. Am J Obstet Gynecol 1981;139:277-282
10. Minjarez DA and Bradshaw KD. Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin North Am 2000;27:63-78
11. Kouides PA. Obstetric and gynaecological aspects of von Willebrand disease. Bailliere's Clin Haematol 2001;14:381-399
12. Bevan JA, Maloney KW, Hillery CA, Gill JC, Montgomery RR, Scott JP. Bleeding disorders: a common cause of menorrhagia in adolescents. Journal of Pediatrics 2001;138:856-861
13. Kadir RA and Aledort LM. Obstetrical nad gynaecological bleeding: a common presenting symptom. Clin Labor Haematol 2000;22(suppl. 1):12-16
14. Laufer MR, Goitein L, Bush M, Cramer DW, Emans SJ. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr Adolesc Gynecol 1997;10:199-202
15. Mammen EF. Haemostatic Dysfunction related to Liver diseases and Liver Transplantation. In Williams Hematology 6th ed by Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, by McGraw-Hill Professional. New York. 2000
16. Goudas VT, Dumesic DA. Polycystic Ovary Syndrome. Endocrinol Metab Clin North Am 1997;26:893-912
17. Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB, Nieman LK, Chrousos GP. Cushing's Syndrome in children and adolescents. N Eng J Med 1994;331:629-636
18. Baird DT, Cameron ST, Critchley HO, Drudy TA, Howe A, Jones RL, Lea RG, Kelly RW. Prostaglandins and menstruation. Eur J Obstet Gynecol Reprod Biol 1996;70:15-17
19. Smith SK, Abel MH, Kelly RW et al. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 1981;88:434-442
20. Adelatando JM, Rees MCP, A López Bernal and AC Turnbull. Increased uterine prostaglandin receptors in mennorhagic women. Br J Obstet Gynaecol 1988;95:162-165
21. Wang IY, Fraser IS, Barsamian SP, Manconi F, Street DJ, Cornillie FJ, Russell P. Endometrial Lysosomal enzyme activity in ovulatory dysfunctional uterine bleeding, IUCD users and postpartum women. Mol Hum Reprod 2000;6 258-263
22. Salamonsen LA, Zhang J, Hampton A and Lathbury L. Regulation of matrix metalloproteinases in human endometrium Hum Reprod 2000;15 (suppl.3):112-119
23. Strickland JL, Wall JW. Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin N Am 2003;30:321-335
24. Long CA and Gast MJ. Menorrhagia. Obstet Gynecol Clin N Am 1990;17:343-359
25. Hesla JS. Dysmenorrhea. In Pediatric and Adolescent Gynecology 2nd Ed: By Sue Ellen K Carpenter, John A Rock By Lippincott Williams & Wilkins Publishers Chapter 15, 2000
26. Dawood MY. Etiology and treatment of dysmenorrhea. Semin Reprod Endocrinol 1985;3:283-294
27. Davis AR, Westhoff CL. Primary Dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol 2001;14:3-8
28. Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol 1982;144:655-660
29. Svanberg L, Ulmsten U. The incidence of primary dysmenorrhea in teenagers. Arch Gynecol 1981;230:173
30. Campbell MA, McGrath PJ. Use of medication by adolescents for the management of menstrual discomfort. Arch Pedriatr Med 1997;151:905
31. Klein JR, Litt IF. Epidemiology of adolescent dysmenorrhea. Pediatrics 1981;68:661-664
32. Widholm O. Dysmenorrhea during adolescence. Acta Obstet Gynecol Scand 1979;87(Suppl):61-66
33. Ylikorkala O, Dawood MY. New concepts in dysmenorrhea. Am J Obstet Gynecol 1989;130:833-847
34. Johnson J. Level of knowledge among adolescent girls regarding effective treatment for dysmenorrhea. J Adoles Health 1988;9:398-413
35. Campbell MA, McGrath PJ. Use of medication by adolescents for the management of menstrual discomfort. Arch Pedriatr Med 1997;151:905-912
36. Campbell MA, McGrath PJ. Non-pharmacologic strategies used by adolescents for the management of menstrual discomfort. Clin J Pain 1999;15:313-321
37. Widholm O, Kantero RL. Correlations of menstrual traits between adolescent girls and their mothers. Acta Obstet Gynecol Scand 1971;50(Suppl 14):30-36
38. Freeman EW, Rickels K, Sondheimer SJ. Premenstrual symptoms and dysmenorrhea in relation to emotional distress factors in adolescents. J Psychosom Obstet Gynaecol 1993;14:41-50
39. Pickles VR. A plain-muscle stimulant in the menstruum. Nature 1957;180:1198-1199
40. Pickles VR, Hall WJ, Best FA, Smith GN. Prostaglandins in endometrium and menstrual fluid from normal and dysmenorrhoeic subjects. J Obstet Gynaecol Br Commonwealth 1965;72:185-192
41. Fraser IS. Prostaglandins, prostaglandin inhibitors and their roles in gynecological disorders. Bailliere's Clin Obstet Gynaecol 1992;6:829-857
42. Rees MC, DiMarzo V, Tippins JR, Morris HR, Turnbull AC. Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhea and menorrhagia. J Endocrinol 1987;113:291
43. Michelassi F, Landa L, Hill RD, Lowenstein E, Watkins WD, Petkau AJ, Zapol WM. Leukotriene 04: A potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science 1982;217:841-852
44. Carraher R, Hahn DW, Ritchie DM, McGuire JL. Involvement of lipoxygenase products in myometrial contractions. Prostaglandins 1983;26:23-37
45. Harel Z, Lilly C, Riggs S, et al. Urinary Leukotriene (LT)- E4 in adolescents with dysmenorrhea. J Adolesc Health 2000;27:151-154
46. Harel Z, Riggs S, Vaz R, Flanagan P, Harel D. The Use of the Leukotriene Receptor Antagonist Montelukast (Singulair) in the Management of Dysmenorrhea in Adolescents. J Pediatr Adolesc Gynecol 2004;17:183-186
47. Haukttsson A, Åkerlund M, Forsling ML, Kindahl H. Plasma concentrations of vasopressin and a prostaglandin F2a metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive. J Endocrinol 1987;115:355-361
48. Åkerlund M. Can primary dysmenorrhea be alleviated by a vasopressin antagonist? Results of a pilot study. Acta Obstet Gynecol Scand 1987;66:459-461
49. Steinwall M, Bossmar T, Gaud C and Akerlund M. Inhibitory effects of SR 49059 on oxytocin and vasopressin-induced uterine contractions in non-pregnant women. Acta Obstet Gynecol Scand 2004;83:12-18
50. Dmitrovic R, Peter B, Cvitkovic-Kuzmic A, Strelec M, Kereshi T. Severity of symptoms in primary dysmenorrhea - a Doppler study. Eur J Obstet Gynecol Reprod Biol 2003;107:191-194
51. Dmitrovic R, Cvitkovic-Kuzmic A, Brkljacic B. Uterine diameters and endometrial thickness in patients with severe primary dysmenorrhea. Int J Gynecol Obstet 2004;85 183-185
52. Yen ML, Chen H-H, So EC, Liu CF. A study of serum malondialdehyde and interleukin-6 levels in young women with dysmenorrhea in Taiwan. Life Sciences 2004;75:669-673
53. Harlow SD, Park M. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol 1996;103:1134-1142
54. Teperi J, Rimpelä M. Menstrual pain, health and behaviour in girls. Soc Sci Med 1989;29:163-169
55. Di Cintio E, Parazzini F, Tozzi L, Luchini L, Mezzopane R, Marchini M, Fedele L. Dietary habits, reproductive and menstrual factors and risk of dysmenorrhoea. European Journal of Epidemiology 1997;13:925-930
56. Deligeorogou E. Dysmenorrhea. Ann N Y Acad Sci 2000;900:237-44
57. Creatsas G, Deligeoroglou E, Zachari A, et al. Prostaglandins: PGF2a, PGE2, 6-keto-PGF1a and TXB serum levels in dysmenorrheic adolescents before, during and after treatment with oral contraceptives. Euro J Obstet Gynecol and Repro Biol 1990;36:292-299
58. Hendrix SL, Alexander NJ. Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive. Contraception 2002;66:393-399
59. Callejo J, Diaz J, Ruiz A, Garcia RM. Effect of a low-dose oral contraceptive containing 20 μg ethinylestradiol and 150 μg desogestrel on dysmenorrhea. Contraception 2003;68:183-188
60. Winkler UH, Ferguson H, Mulders JA. Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 μg ethinylestradiol. Contraception 2004;69:469-476
61. Wildemeersch D, Schacht E, Wildemeersch P. Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study. Eur J Contracept Reprod Health Care 2001;6:192-198
62. Harel Z. A contemporary approach to dysmenorrhea in adolescents. Paediatr Drugs 2002;4:797-805
63. Smith RP, Powell JR. Simultaneous objective and subjective evaluation of meclofenamate sodium in the treatment of primary dysmenorrhea. Am J Obstet Gynecol 1987;157:611-618
64. DuRant RH, Jay MS, Shofitt T. Factors influencing adolescents' responses to regimens of naproxen for dysmenorrhea. Am J Dis Childr 1985;139:489-497
65. Marjoribanks J, Proctor ML, Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst Rev 2003;4:CD001751
66. Harel Z. Cyclooxygenase-2 specific inhibitors in the treatment of dysmenorrhea. J Pediatr Adolesc Gynecol. 2004;17:75-79
67. Akerlund M, Andersson KE, Ingemarsson J. Effects of terbutaline on myometrial activity, uterine blood flow, and lower abdominal pain in women with primary dysmenorrhea. Br J Obstet Gynaecol 1976;83:673-678
68. Saldeen P, Saldeen T. Women and omega-3 Fatty acids. Obstet Gynecol Surv 2004;59:722-30
69. Morgan PJ, Kung R, Tarshis J. Nitroglycerin as a uterine relaxant: a systematic review. J Obstet Gynaecol Can 2002;24:403-409
70. Wilson ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2001;3: CD002124
71. Laufer MR, Goitein L, Bush M, Cramer DW, Emans SJ. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr Adolesc Gynecol 1997;10:199-202